Covered Transjugular Intrahepatic Portosystemic Shunt Improves Hypersplenism-Associated Cytopenia in Cirrhosis.

"Declarations Conflict of interestMattias Mandorfer served as a speaker and/or consultant and/or advisory board member for W.L. Gore and Associates. Thomas Reiberger received grant support and speaking honoraria from W.L. Gore and Associates. Maria Schoder served as a speaker and/or consultant and/or advisory board member for W.L. Gore and Associates. Ethics approvalThis study was conducted in accordance with the Declaration of Helsinki and its later amendments. It was approved by the Ethics Committees of the Medical University of Vienna (1760/2014) and of the City of Vienna (MA15, 14–264-VK). This research study was conducted retrospectively from data obtained for clinical purposes, and all the procedures being performed were part of the routine care. Due to the retrospective nature of the study, the need for informed patient consent was waived by the local Ethics Committees. Conflict of interest Mattias Mandorfer served as a speaker and/or consultant and/or advisory board member for W.L. Gore and Associates. Thomas Reiberger received grant support and speaking honoraria from W.L. Gore and Associates. Maria Schoder served as a speaker and/or consultant and/or advisory board member for W.L. Gore and Associates."

"Funding Open access funding provided by Medical University of Vienna. The authors received no financial support for the research, authorship, and/or publication of this article."